Skip to main content
. 2021 Jan 7;105(3-4):169–180. doi: 10.1159/000510407

Table 2.

Levels of evidence according to the Oxford Centre for Evidence-Based Medicine 2009 classification system (from [18])

Level of evidence Diagnostics Therapy
Ia SR (with homogeneity*) of level 1 diagnostic studies; clinical decision rule with 1b studies from different clinical centres SR (with homogeneity*) of RCTs

Ib Validating cohort study with good reference standards or clinical decision rule tested within 1 clinical centre Individual RCT (with narrow confidence interval)

Ic Absolute SpPins and SnNouts All or none principle

IIa SR (with homogeneity*) of level >2 diagnostic studies SR (with homogeneity) of cohort studies

IIb Exploratory cohort study with good reference standards, clinical decision rule after derivation, or validated only on split-sample or databases Individual cohort study (including low quality RCT)

IIc Outcomes research, ecological studies

IIIa SR (with homogeneity*) of 3b and better studies SR (with homogeneity) of case-control studies

IIIb Non-consecutive study, or without consistently applied reference standards Individual case-control study

IV Case-control study, poor or non-independent reference standard Case series (and poor-quality cohort and case-control studies)

V Expert opinion without explicit critical appraisal, or based on physiology, bench research or first principles Expert opinion without explicit critical appraisal, or based on physiology, bench research or first principles

RCT, randomized control trial; SR, systematic review.

*

By homogeneity, we mean a systematic review that is free of worrisome variations (heterogeneity) in the directions and degrees of results between individual studies. Not all systematic reviews with statistically significant heterogeneity need be worrisome, and not all worrisome heterogeneity need be statistically significant.